Organicell Fundamentals

OCEL
 Stock
  

USD 0.04  0.004  11.11%   

Organicell Regenerative Medicine fundamentals help investors to digest information that contributes to Organicell Regenerative's financial success or failures. It also enables traders to predict the movement of Organicell OTC Stock. The fundamental analysis module provides a way to measure Organicell Regenerative's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organicell Regenerative otc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Organicell EBITDA Analysis

Organicell Regenerative's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current Organicell Regenerative EBITDA

    
  (5.18 M)  
Most of Organicell Regenerative's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organicell Regenerative Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Compare to competition

According to the company disclosure, Organicell Regenerative Medicine reported earnings before interest,tax, depreciation and amortization of (5.18 Million). This is 100.59% lower than that of the Healthcare sector and 105.17% lower than that of the Biotechnology industry. The ebitda for all United States stocks is 100.13% higher than that of the company.

Organicell Regenerative Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Organicell Regenerative's current stock value. Our valuation model uses many indicators to compare Organicell Regenerative value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organicell Regenerative competition to find correlations between indicators driving Organicell Regenerative's intrinsic value. More Info.
Organicell Regenerative Medicine is considered to be number one stock in price to sales category among related companies. It is considered to be number one stock in operating margin category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Organicell Regenerative by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Organicell Regenerative's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organicell Regenerative's earnings, one of the primary drivers of an investment's value.

Organicell Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organicell Regenerative's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Organicell Regenerative could also be used in its relative valuation, which is a method of valuing Organicell Regenerative by comparing valuation metrics of similar companies.
Organicell Regenerative is currently under evaluation in market capitalization category among related companies.

Organicell Fundamentals

About Organicell Regenerative Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Organicell Regenerative Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organicell Regenerative using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organicell Regenerative Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Organicell Regenerative without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Organicell Regenerative using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Organicell Regenerative Piotroski F Score and Organicell Regenerative Altman Z Score analysis. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.